Parkinson

A new organoid model of the dopaminergic system sheds lights on its intricate functionality and potential implications for Parkinson's disease. The model, developed by the group of Jürgen Knoblich at the Institute of Molecular Biotechnology…

What happens in the human brain when we learn from positive and negative experiences? To help answer that question and better understand decision-making and human behavior, scientists are studying dopamine. Dopamine is a neurotransmitter…

By PTI NEW DELHI: Nanoplastics interact with a particular protein naturally found in the brain creating changes linked to Parkinson's disease and some types of dementia, a study has found. The research, published in…

By MATTHEW BARAKAT - Associated Press FALLS CHURCH, Va. (AP) — U.S. Rep. Jennifer Wexton, a Democrat, announced Monday she won't seek reelection in her competitive district in the northern…

A new Northwestern Medicine study challenges a common belief in what triggers Parkinson's disease. Degeneration of dopaminergic neurons is widely accepted as the first event that leads to Parkinson's. But the new study suggests that a…

Ask any neurologist: Parkinson's disease is a brain disorder. The conspicuous symptoms of Parkinson's disease -- uncontrollable tremors, slowed down motions, and the feeling that one's feet are stuck to the ground -- all stem from the loss…

Identification of risk factors for Parkinson's disease (PD) is essential for early diagnosis. Dating back to the 1920s, Parkinson's disease and parkinsonism -- an umbrella term that refers to motor symptoms found in Parkinson's disease and…

Northwestern Medicine scientists have uncovered a new mechanism by which mutations in a gene parkin contribute to familial forms of Parkinson's disease. The discovery opens a new avenue for Parkinson's therapeutics, scientists report in a…

Scientists from Scripps Research and Cardiff University made key discoveries in support of a new stem cell-based therapy for Parkinson's disease. The approach, called an autologous therapy, uses induced pluripotent stem cells (iPSCs) --…

It is likely that in the early stages of Parkinson's disease, basal dopamine levels in the brain remain sufficiently high for many years, despite the gradual loss of dopamine-producing neurons. NEW DELHI: Parkinson's may progress…